Greystar buys Greenford site for giant PRS scheme

Wednesday, January 27, 2016 | Paul Norman

Greystar Europe Holdings has bought, with an institutional partner, the 26.5 acre site former GlaxoSmithKline site in Greenford, West London for a major purpose built rental housing led scheme.


The site, formerly home to the GlaxoSmithKline and J. Lyons & Co. operations, will comprise mixed use development with a significant focus on rental housing but also including for-sale residential, employment, active retail, amenity, and community uses.

Greystar said that upon completion it will be the largest purpose built rental housing development created in the UK.

The development is part of Greystar’s plans to introduce its multifamily proposition to the UK market.

Greystar is the largest multifamily operator in the US and a large operator of student housing in the UK, and manages over 410,000 residences worldwide.

For entire article, click View More below.
 
Media Resources
View our PRESS KIT
Press Release Archives
  • Wednesday, September 16, 2020
    Greystar Makes Strategic Investment in Thackeray Partners

    Read More

  • Tuesday, September 8, 2020
    Greystar Announces First Album 55+ Active Adult Community

    Read More

  • Tuesday, September 1, 2020
    Greystar joins CPP Investments and Cyrela in Development of Brazilian Multifamily Property Sector

    Read More

  • Wednesday, August 26, 2020
    Multifamily Executive: Greystar Has Right Ingredients for Growth

    Read More

  • Monday, August 24, 2020
    Greystar Announces New Active Adult Development in Winter Garden, Florida

    Read More

View All Archives